All News #Library
Sciences
Seres Therapeutics to Present SER-109 Phase 3 ECOSPOR III Study Results
12 Oct 2020 //
BUSINESSWIRE
Engineered bacteria prime solid tumors for immunotherapy
08 Jul 2019 //
FIERCE BIOTECH

Market Place
Sourcing Support